Combination therapy comprising olaratumab and doxorubicin

摘要

Combination of olaratumab, a human antibody that binds to human platelet-derived growth factor receptor alpha (PDGFR alpha), and doxorubicin together with dexrazoxane as a medicament for the treatment of soft tissue sarcoma.